Clinical Trial Update: Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bisphosphonate therapy for HIV-infected adults with decreased bone mineral density.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Osteopenia
• Osteoporosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Osteopenia | Phase 2 | Status: UNKNOWN